On Friday, Shares of Ford Motor Co. (NYSE:F), lost -1.79% to $14.78.
Hundreds of Ford Volunteer Corps members across the U.S. are digging into community environmental projects recently, part of a Ford Motor Company Accelerated Action Day aimed at building stronger communities on World Environment Day.
About 500 Ford employees will take part in more than three dozen essential community service projects created by Ford’s nonprofit partners, counting building urban vegetable gardens and renovating outdoor facilities. Many of the participating agencies will share more than $47,000 in Ford grants to buy the tools, plants and other materials needed to complete the day’s work.
Ford employees also teamed up once again with Ford Green IT to collect unused computers, printers and other electronic equipment for recycling. During last year’s collection, more than 75,000 pounds of e-waste was collected, recycled and kept out of landfills. A similar amount is predictable when this year’s results are tallied.
Ford Motor Company manufactures and distributes automobiles worldwide. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services vehicles, parts, and accessories.
Shares of Evolent Health, Inc. (NYSE:EVH), inclined 10.94% to $18.86, during its last trading session, hitting its highest level.
Evolent Health, has priced its initial public offering of 11,500,000 shares of Class A common stock at a price to the public of $17.00 per share.
The underwriters have been granted an option to purchase up to 1,725,000 additional shares of Class A common stock from Evolent at the initial public offering price, less underwriting discounts and commissions. Evolent’s Class A common stock has been approved for listing on the New York Stock Exchange under the symbol “EVH”, subject to official notice of issuance.
J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint bookrunners for the offering. Wells Fargo Securities, LLC, William Blair & Company, L.L.C., SunTrust Robinson Humphrey, Inc. and Leerink Partners LLC are acting as co-managers.
Evolent Health partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent assists physicians and health systems achieve superior quality and cost results. Evolent’s approach breaks down barriers, aligns incentives and powers a new model of care delivery resulting in meaningful alignment between providers, payers, physicians and patients.
At the end of Friday’s trade, Shares of Noble Corporation plc (NYSE:NE), gained 1.30% to $17.08, despite Oil prices fell on Friday as the dollar rose and after OPEC kept its oil production target unchanged for another six months.
Oil futures settled higher Friday, with gains for the U.S. benchmark intensifying in the last few minutes of trading after a report showing a 26th straight weekly decline in the number of U.S. rigs actively drilling for oil.
The news outweighed pressure from the Organization of the Petroleum Exporting Countries’ decision not to change its production ceiling.
Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units. As of December 31, 2014, the company operated a fleet of 15 jackups, 9 drillships, and 8 semisubmersibles, counting 1 high-specification, harsh environment jackup under construction. Noble Corporation plc was founded in 1921 and is headquartered in London, United Kingdom.
Finally, Veeva Systems Inc. (NYSE:VEEV), ended its last trade with 0.66% gain, and closed at $27.62.
Veeva Systems, is among the top three most preferred life sciences software vendors, according to IDC Health Insights’ Leading Indicators in Life Sciences IT Spending Surveyi, which measures planned investments for 2015. This is the third year that Veeva has been among the top ten vendors, and has been steadily increasing its standing among life sciences executives over the past three years – jumping to 3rd most preferred provider from 8th two years ago.
Veeva delivers industry cloud software solutions to assist life sciences companies achieve their most pressing planned objectives – bringing drugs to market faster and more efficiently, maximizing revenues, and maintaining compliance with government regulations. Veeva was the only industry cloud vendor to top the list.
In addition to its most preferred status, Veeva has been named a ‘Leader’ in the IDC Marketscape Worldwide Life Science CRM Software 2015 Vendor Assessment, and ranked the 3rd life sciences software vendor globally by IDC Health Insights’ Vendor Assessment: 2014 Top 10 Life Science Software Vendors report. Veeva climbed two positions this year from last year’s rankings.
Veeva Systems Inc. provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. Its solutions comprise Veeva CRM, a customer relationship administration solution that allows pharmaceutical and biotechnology companies to market and sell compliantly to physicians, other healthcare professionals, and healthcare organizations through multiple touch points, counting face-to-face, email, and online; and Veeva Vault, a cloud-based content administration and partnership solution for its customers to manage content-centric processes in various departments within a life sciences company, counting clinical trials, regulatory submissions, quality administration, manufacturing, medical, sales, and marketing.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
